Pulmonary Disease Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
VTVT	F	vTv Therapeutics Inc.	0.97
APLS	F	Apellis Pharmaceuticals, Inc.	-9.09
DVAX	F	Dynavax Technologies Corporation	-2.50
LUNG	D	Pulmonx Corporation	-6.08
OPK	C	OPKO Health Inc.	-3.17
GTLS	C	Chart Industries, Inc.	-4.49
INGN	C	Inogen, Inc	-1.62
PULM	B	Pulmatrix, Inc.	8.29
AMED	A	Amedisys Inc	0.03
INVA	A	Innoviva, Inc.	2.39

Symbol	Grade	Name	Weight
IWV	B	iShares Russell 3000 ETF	8.0
ITOT	B	iShares Core S&P Total U.S. Stock Market ETF	7.0
IWM	B	iShares Russell 2000 ETF	6.0
GERM	B	ETFMG Treatments Testing and Advancements ETF	5.51
PBE	A	PowerShares Dynamic Biotech & Genome	5.11

Compare ETFs

Compare IWM to PBE Compare IWV to IWM Compare IWV to PBE

Date	Stock	Title
Aug 1	APLS	Apellis Pharmaceuticals, Inc. (APLS) Q2 2024 Earnings Call Transcript
Aug 1	OPK	OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
Aug 1	GTLS	Chart Industries Q2 2024 Earnings Preview
Aug 1	APLS	Apellis (APLS) Q2 Earnings Beat, Syfovre Sales Drive Revenues
Aug 1	APLS	Compared to Estimates, Apellis Pharmaceuticals (APLS) Q2 Earnings: A Look at Key Metrics
Aug 1	APLS	Apellis Pharmaceuticals, Inc. (APLS) Reports Q2 Loss, Tops Revenue Estimates
Aug 1	APLS	Apellis Pharmaceuticals GAAP EPS of -$0.30 beats by $0.02, revenue of $199.69M beats by $8.38M
Aug 1	APLS	Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results
Aug 1	LUNG	Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript
Jul 31	INVA	Innoviva: Q2 Earnings Snapshot
Jul 31	LUNG	Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates
Jul 31	INVA	Innoviva GAAP EPS of -$0.55, revenue of $99.9M
Jul 31	LUNG	Pulmonx GAAP EPS of -$0.39
Jul 31	INVA	Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
Jul 31	LUNG	Pulmonx Reports Second Quarter 2024 Financial Results
Jul 31	APLS	Apellis Pharmaceuticals Q2 2024 Earnings Preview
Jul 31	GTLS	IAC Gears Up to Report Q2 Earnings: Here's What to Expect
Jul 30	GTLS	Exploring Analyst Estimates for Chart Industries (GTLS) Q2 Earnings, Beyond Revenue and EPS
Jul 30	APLS	When Will Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Breakeven?
Jul 29	LUNG	Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Pulmonary Disease: Pulmonary disease is a broad term that refers to any disease or disorder that affects the lungs. This includes conditions such as asthma, COPD, pneumonia, and lung cancer. Pulmonary diseases can be caused by a variety of factors, including environmental pollutants, smoking, and genetics. Treatment for pulmonary diseases varies depending on the type and severity of the condition.